The Q8 Pro is a point-of-care fluorescence immunoassay analyzer designed for rapid clinical testing in laboratory and bedside settings. It performs quantitative immunoassay measurements for cardiac markers, hormones, and infectious disease detection with automated sample processing and results repor...
Manufactured by
Chongqing Sichuan, China
Zybio Inc. is a high-tech enterprise specialized in R D, manufacture, sales and technical services of in vitro diagnostic reagents and equipment, with the headquarter and manufacturing center located in Dadukou District, Chongqing. Zybio has more than 3,300 employees worldwide, of which R D personnel account for more than 30% . Nearly 50% of R D personnel have master's degree or above. The company compared to spend no less than 15% of sales revenue on its research and development. As a postdoctoral programme, Zybio is dedicated to attract more talents to focus on the cutting-edge technology in IVD field and take product research and development as the core driving force in the future s continuous and rapid development. We have established several R D centers distributed in China, like Chongqing R D center, Beijing R D center, Guangzhou R D center, Shenzhen R D center, Nanjing R D center Xiamen R D center and Changchun R D center . The company s main product covers clinical chemistry, immunoassay, molecular diagnosis, POCT, hematology, microbiology, pathological and other diagnostic products. It also has a comprehensive layout in core technical fields such as biological raw materials and chemical raw materials. The company has developed a wide range of core technologies such as genetic engineering antigens/antibodies, diagnostic nanomaterials, high-precision diagnostic equipment and core component, multiple label signal amplification, and rapid nucleic acid extraction and detection. Till now, we have obtained nearly 500 product registration certificates and nearly 60 invention patents. Zybio officially established a standardized reference measurement laboratory in 2018 and some key clinical chemistry items have passed the quality evaluation of International Federation of Clinical Chemistry and Laboratory Medicine (IFCC-RELA). Zybio has 100,000 m2 manufacture plant, equipped with a modern qualified production workshop, and has 19 production lines including reagents and equipment. We have setup an international standard quality system and our products have passed ISO 90001 and ISO 13485. All products have passed strict quality inspection before shipping. The current production capacity can reach 3.0 billion kits of reagent and 35,000 equipment per year. Zybio has became a leading enterprise in the field of medical equipment and one of the top 100 manufacturing enterprise in Chongqing. In order to provide comprehensive service for our customers, Zybio has developed broad marketing system worldwide. In China, we have established 79 service teams across 31 provinces, with the service ability of 1 hour response, 12 hours on-site . Also, we have set up local marketing service system in overseas. Until now, our products have been sold to over 100 countries, including Asia, South America, North America, Europe and Africa. Our products and solutions are applied in more than 13,000 hospitals worldwide. Dedication To Accuracy , Zybio will continue to meet the various needs of customers, focus on innovation in IVD industry. We would cooperate deeply with global medical institutions to create greater value for customers and continuously strive for creating an international superb IVD brand!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai STAC Biotechnology Co., Ltd.
China · 1 relevant product
Chengdu Illumaxbio Technology Co.,LTD
China · 2 relevant products
Wuhan Life Origin Biotech Joint Stock Co., Ltd.
China · 1 relevant product
Jiangsu Zecen Biotechnology Co., Ltd
China · 1 relevant product
Shenzhen Microprofit Biotech Co., Ltd
China · 1 relevant product
B&C Biological
China · 3 relevant products
OptiBio Co., Ltd.
South Korea · 1 relevant product
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
Reckon Diagnostics Pvt Ltd
India · 1 relevant product
Assure Tech. (Hangzhou) Co., Ltd.
China · 1 relevant product
13 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 27 closest product alternatives
Shanghai STAC Biotechnology Co., Ltd. · China
POCT dry fluorescence immunoassay test kits and immunoanalyzer for rapid point-of-care diagnostics. Designed for hematology and clinical chemistry applications with integrated reagent, calibrator, and control solutions. CE and ISO 13485 certified with compatibility across leading analyzer platforms.
Chengdu Illumaxbio Technology Co.,LTD · China
Automatic fluorescence immunoassay system for point-of-care testing delivering core-laboratory precision results. The P16 X-POCT platform performs chemiluminescent immunoassay analysis with multiplex capability, enabling rapid clinical diagnostics in decentralized care settings. Ready-to-use test cartridges and integrated analyzer reduce turnaround time for infectious disease, cardiac, and immunology testing.
Wuhan Life Origin Biotech Joint Stock Co., Ltd. · China
Fluorescence immunoassay POCT rapid diagnostic kits for point-of-care testing, enabling quick detection of biomarkers at the bedside or clinical setting. These kits utilize fluorescence technology to deliver sensitive and specific results without requiring centralized laboratory infrastructure, supporting rapid clinical decision-making.
Chengdu Illumaxbio Technology Co.,LTD · China
Portable chemiluminescence immunoassay analyzer (POCT CLIA) for point-of-care diagnostics. The Lumilite 8 system delivers core laboratory precision with compact design, enabling rapid immunoassay testing in clinical settings. Supports single-test and multiplex assay protocols for streamlined diagnostic workflows.
Jiangsu Zecen Biotechnology Co., Ltd · China
Point-of-care testing chemiluminescence system for rapid diagnostic testing. Designed for use in hospitals, disease control centers, and health examination centers.
Shenzhen Microprofit Biotech Co., Ltd · China
CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.
B&C Biological · China
A POCT-series chemiluminescence immunoassay analyzer designed for point-of-care diagnostic testing. This instrument is part of B&C Biological's POCT product line for rapid immunodiagnostic applications in clinical settings.
OptiBio Co., Ltd. · South Korea
Multi-parameter fluorescence immunoassay diagnostic test kits enabling point-of-care testing for 20+ clinical parameters. These POCT reagents provide rapid, sensitive detection across infectious disease, cardiac, and metabolic markers, supporting timely clinical decision-making in resource-limited and acute care settings.
guangzhou biotron technolongy co.,ltd · China
Point-of-care testing platform based on immunochemical principles for rapid on-site diagnostic testing without laboratory infrastructure requirements.
Reckon Diagnostics Pvt Ltd · India
Point-of-care test kits utilizing immunofluorescence technology for rapid diagnostic applications. These kits are designed for quick and efficient diagnostic testing in clinical settings.
Assure Tech. (Hangzhou) Co., Ltd. · China
POCT Chronic Disease Monitoring Systems enable rapid point-of-care testing for chronic disease management through colloidal gold and chemiluminescence immunoassay technologies. The platform supports multiple diagnostic test series including cardiac markers, biochemical parameters, and disease monitoring. Designed for clinical laboratories and healthcare facilities requiring quick, quantitative diagnostic results.
Beijing Sinomedisite Bio-tech Co., Ltd · China
Fluorescence immunochromatography analyzer for rapid point-of-care testing (POCT) and clinical diagnostics. Detects biomarkers and analytes using fluorescence-based immunoassay technology for disease screening and monitoring. Integrates with chronic disease management systems for automated result processing and data management.
15 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products